
UK’s competition watchdog on Tuesday launched an investigation into suspected anti-competitive conduct involving a number of unnamed vehicle manufacturers and some industry bodies for not recycling old or discarded vehicles.
The Competition and Markets Authority (CMA) said it was working closely along with the European Commission, which also launched an investigation into the matter on Tuesday.
The CMA’s probe relates to arrangements for recycling old vehicles, particularly cars and vans, known in the industry as ‘end-of-life vehicles’ (ELV). Existing regulations cover all cars and small vans, including components made for them, and include requirements for the materials allowed, as well as for disposal procedures of said materials. End-of-life vehicles (ELVs) are motor categorised as waste, generally due to age or accident.
The British regulator said the ELVs are required to be disposed of in a sustainable way and carmakers must offer customers a free service for recycling ELVs – a service manufacturers often outsource to third parties. Under current rules, the responsibility for compliance lies squarely on motor vehicle producers.
The European antitrust regulator in a separate statement said it has conducted unannounced inspections at the premises of companies and associations in the automotive sector located in the bloc, without naming any.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas